StockWatch
·

AAREY DRUGS & PHARMACEUTICALS LTD. Q3 FY26 Results

AAREYDRUGSQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue96.4314.6%27.9%
Total Income100.6118.4%25.2%
Expenditure99.6819.4%25.1%
PBT0.9237.6%34.0%
Net Profit1.2824.9%78.0%
OPM-1.57%4.71pp1.00pp
NPM1.27%0.07pp0.74pp
EPS0.2044.4%23.1%
View full financials

Informational and educational content only. Not investment advice.